These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38540125)
1. Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report. Castellanos G; Pardo L; López A; Cornago J; López JL; de Las Heras A; Díaz FJ; Martínez de Bourio M; Castillo E; Llamas P; Solán L Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540125 [TBL] [Abstract][Full Text] [Related]
2. Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study. Candoni A; Lazzarotto D; Ferrara F; Curti A; Lussana F; Papayannidis C; Del Principe MI; Bonifacio M; Mosna F; Delia M; Minetto P; Gottardi M; Fracchiolla N; Mancini V; Forghieri F; Zappasodi P; Cerrano M; Vitale A; Audisio E; Trappolini S; Romani C; Defina M; Imbergamo S; Ciccone N; Santoro L; Cambò B; Iaccarino S; Dargenio M; Aprile L; Chiaretti S; Fanin R; Pizzolo G; Foà R Am J Hematol; 2020 Dec; 95(12):1466-1472. PubMed ID: 32777149 [TBL] [Abstract][Full Text] [Related]
3. Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma. Abaza Y; M Kantarjian H; Faderl S; Jabbour E; Jain N; Thomas D; Kadia T; Borthakur G; D Khoury J; Burger J; Wierda W; O'Brien S; Konopleva M; Ferrajoli A; Kebriaei P; Dabaja B; Kornblau S; Alvarado Y; Daver N; Pemmaraju N; Bose P; Thompson P; Al Azzawi H; Kelly M; Garris R; Jain P; Garcia-Manero G; Cortes J; Ravandi F Am J Hematol; 2018 Jan; 93(1):91-99. PubMed ID: 29047158 [TBL] [Abstract][Full Text] [Related]
4. Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases. Molle I; Petruskevicius I; Kamper P; d'Amore F Case Rep Hematol; 2022; 2022():9722787. PubMed ID: 35047223 [TBL] [Abstract][Full Text] [Related]
5. Safety of nelarabine in adults with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma. Candoni A; Lazzarotto D; Petruzzellis G Expert Opin Drug Saf; 2021 Jul; 20(7):751-756. PubMed ID: 33866913 [TBL] [Abstract][Full Text] [Related]
6. Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia. Fulcher J; Berardi P; Christou G; Villeneuve PJA; Bredeson C; Sabloff M Leuk Lymphoma; 2021 Sep; 62(9):2295-2297. PubMed ID: 33749497 [No Abstract] [Full Text] [Related]
7. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Kodama Y; Manabe A; Kawasaki H; Kato I; Kato K; Sato A; Matsumoto K; Kato M; Hiramatsu H; Sano H; Kaneko T; Oda M; Saito AM; Adachi S; Horibe K; Mizutani S; Ishii E; Shimada H Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28084041 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis. Kathpalia M; Mishra P; Bajpai R; Bhurani D; Agarwal N Ann Hematol; 2022 Aug; 101(8):1655-1666. PubMed ID: 35727338 [TBL] [Abstract][Full Text] [Related]
9. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. DeAngelo DJ; Yu D; Johnson JL; Coutre SE; Stone RM; Stopeck AT; Gockerman JP; Mitchell BS; Appelbaum FR; Larson RA Blood; 2007 Jun; 109(12):5136-42. PubMed ID: 17344466 [TBL] [Abstract][Full Text] [Related]
10. The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience. Dyakonova YY; Bydanov OI; Popov AM; Olshanskaya YV; Boichenko EG; Aleynikova OV; Maschan MA; Shelikhova LN; Litvinov DV; Khachatryan LA; Ponomareva NI; Fechina LG; Novichkova GA; Pashanov ED; Karachunskiy AI Ter Arkh; 2018 Aug; 90(7):38-50. PubMed ID: 30701921 [TBL] [Abstract][Full Text] [Related]
11. FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma. Cohen MH; Johnson JR; Justice R; Pazdur R Oncologist; 2008 Jun; 13(6):709-14. PubMed ID: 18586926 [TBL] [Abstract][Full Text] [Related]
12. [Severe consciousness disturbance after cord blood transplantation for relapsed T lymphoblastic lymphoma]. Nakamura N; Mizumoto C; Sugimoto A; Fujimoto M; Ayaki T; Takaori-Kondo A Rinsho Ketsueki; 2024; 65(1):47-51. PubMed ID: 38311389 [TBL] [Abstract][Full Text] [Related]
14. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group. Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992 [TBL] [Abstract][Full Text] [Related]
15. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
16. Nelarabine for T cell acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation: an opportunity to improve survival. Forcade E; Leguay T; Vey N; Baruchel A; Delaunay J; Robin M; Socié G; Dombret H; Peffault de Latour R; Raffoux E Biol Blood Marrow Transplant; 2013 Jul; 19(7):1124-6. PubMed ID: 23648236 [TBL] [Abstract][Full Text] [Related]
17. Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. DeAngelo DJ Hematol Oncol Clin North Am; 2009 Oct; 23(5):1121-35, vii-viii. PubMed ID: 19825456 [TBL] [Abstract][Full Text] [Related]